Skip to search.
 STI Down1.77%

Protalix BioTherapeutics, Inc. (PLX)

-ASE

5.20 0.00(0.00%) 04:02 SGT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Net Income (11,618) (36,529) (28,998)
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,692  3,631  3,133  
Adjustments To Net Income7,820  1,385  1,042  
Changes In Accounts Receivables243  3,891  (6,860)
Changes In Liabilities2,977  6,147  (1,029)
Changes In Inventories(3,760)910  (1,189)
Changes In Other Operating Activities1,281  (3,005)(4,563)
Total Cash Flow From Operating Activities 635   (23,570) (38,464)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(2,068)(5,705)(7,855)
Investments -   -   -  
Other Cash flows from Investing Activities(218)(163)(137)
Total Cash Flows From Investing Activities (2,286) (5,868) (7,992)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock26,558  20,927  501  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 26,558   20,927   501  
Effect Of Exchange Rate Changes127  (388)589  
Change In Cash and Cash Equivalents 25,034   (8,899) (45,366)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.